v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:        
Net loss $ (7,635) $ (17,809) $ (20,480) $ (23,713)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 8 29 16 59
Stock-based compensation     816 902
Change in fair value of warrant liability 7 560 (10,763) 560
Loss on issuance of warrant liabilities 0 10,352 15,158 10,352
Operating lease, net     (16) 116
Transaction costs allocated to warrant liabilities     695 1,207
Changes in operating assets and liabilities:        
Prepaid expenses and other assets     (653) (1,503)
Accounts payable     829 1,526
Accrued expenses and other current liabilities     1,630 348
Net cash used in operating activities     (12,768) (10,146)
Cash flows from investing activities:        
Net cash used in investing activities     0 0
Cash flows from financing activities:        
Proceeds from sale of common stock, pre-funded and common warrants and warrant inducement, net of issuance and transaction costs     7,608 13,412
Proceeds from exercise of warrants     2,817 10
Proceeds from issuance of common stock under at-the-market equity program, net of transaction costs     800 0
Net cash provided by financing activities     11,225 13,422
Effect of exchange rate changes on cash and cash equivalents     (73) 3
Net increase (decrease) in cash and cash equivalents     (1,616) 3,279
Cash and cash equivalents - beginning of period     8,878 4,278
Cash and cash equivalents - end of period 7,262 7,557 7,262 7,557
Non-cash investing and financing activities:        
Equity warrants issued in relation to liability classified warrant inducements     23,435 0
Reclassification of warrant liabilities to equity upon contractual reset of exercise price     12,675 0
Deemed dividends in connection with warrant amendments $ 329 $ (0) 2,094 (0)
Offering costs included in accounts payable and accrued liabilities     0 553
Transaction costs related to the sale of common stock, pre-funded and common warrants, and warrant inducements     $ 0 $ 584